INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,888 | +164.7% | 6,650 | +121.2% | 0.00% | – |
| Q2 2023 | $63,437 | +28.9% | 3,007 | +4.1% | 0.00% | – |
| Q1 2023 | $49,222 | -7.1% | 2,889 | +9.7% | 0.00% | – |
| Q4 2022 | $52,993 | -8.6% | 2,634 | -3.5% | 0.00% | – |
| Q3 2022 | $58,000 | +16.0% | 2,730 | +9.2% | 0.00% | – |
| Q2 2022 | $50,000 | -5.7% | 2,500 | +11.8% | 0.00% | – |
| Q1 2022 | $53,000 | -8.6% | 2,236 | +4.5% | 0.00% | – |
| Q4 2021 | $58,000 | +52.6% | 2,140 | +56.4% | 0.00% | – |
| Q3 2021 | $38,000 | +26.7% | 1,368 | +25.2% | 0.00% | – |
| Q2 2021 | $30,000 | -61.0% | 1,093 | -51.0% | 0.00% | – |
| Q1 2021 | $77,000 | +18.5% | 2,232 | +12.7% | 0.00% | – |
| Q4 2020 | $65,000 | +22.6% | 1,981 | +16.5% | 0.00% | – |
| Q3 2020 | $53,000 | +39.5% | 1,701 | +17.9% | 0.00% | – |
| Q2 2020 | $38,000 | +81.0% | 1,443 | +14.6% | 0.00% | – |
| Q1 2020 | $21,000 | – | 1,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |